Last reviewed · How we verify
quinisocaine
quinisocaine is a drug. It is currently in unknown development.
Quinisocaine is a small molecule with the synonyms NSC-39695, QUINISOCAINA, QUINISOCAINE, and is used as a topical anesthetic and antipruritic. It is applied topically to relieve itching and pain.
At a glance
| Generic name | quinisocaine |
|---|---|
| Target | Sodium channel alpha subunits; brain (Types I, II, III) |
| Therapeutic area | Other |
| Phase | unknown |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- quinisocaine CI brief — competitive landscape report
- quinisocaine updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about quinisocaine
What is quinisocaine?
quinisocaine is a pharmaceutical drug.
What development phase is quinisocaine in?
quinisocaine is in unknown.
What does quinisocaine target?
quinisocaine targets Sodium channel alpha subunits; brain (Types I, II, III).
Related
- Target: All drugs targeting Sodium channel alpha subunits; brain (Types I, II, III)
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing